Human iPS cell model of type 3 long QT syndrome recapitulates drug-based 
phenotype correction

Malan, Daniela; Zhang, Miao; Stallmeyer, Birgit; Müller, Jovanca; Fleischmann, Bernd K.; Schulze-Bahr, Eric; Sasse, Philipp; Greber, Boris

doi:10.1007/s00395-016-0530-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction

MPS-Authors

/persons/resource/persons140341

Zhang, Miao
Chemical Genomics Center of the MPS, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons123653

Greber, Boris
Chemical Genomics Center of the MPS, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Malan, D., Zhang, M., Stallmeyer, B., Müller, J., Fleischmann, B. K., Schulze-Bahr, E., et al. (2016). Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Research in Cardiology, 111(2): 14, pp. 14:1-14:11. doi:10.1007/s00395-016-0530-0.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-7764-D

Abstract

There is no abstract available